Upload
madalina-rotaru
View
269
Download
6
Embed Size (px)
Citation preview
7/24/2019 tehnologie farmaceutic
1/53
TEHNOLOGIE FARMACEUTIC, FARMACIE AN IV, SEM. II, LP. 6, 23-27. 03. 2015
PREPARATE SEMISOLIDE PENTRU APLICAII CUTANATE(PRAEPARATIONES MOLLES AD USUM DERMICUM) FR X, SUPLIMENT 2004
UNGUENTE (UNGUENTA) - FR X
Pre!r!"e#e $e%&$'#&(e e)"r* !#&+!re +*"!)!" $*)" (e$"&)!"e *)e& e#&err& #'+!#e $!*
"r!)$(er%&+e ! $*$"!)e#'r !+"&/e $!* e)"r* !+&*)e! #'r r'"e+"'!re $!* e%'#&e)". E#e !* !$e+"
'%'e). FR , S*#. 2004
U)*e)"e#e $*)" re!r!"e !r%!+e*"&+e $e%&$'#&(e (e$"&)!"e !#&+r&& e &e#e $!* e
%*+'!$e, &) $+' "er!e*"&+ $!* (e r'"e+&e $*)" +')$"&"*"e (&) e+&&e)& !8e (e *)*e)"4 &) +!re
$e (&$er$e!8 $*$"!)e %e(&+!%e)"'!$e.
9) *)+&e (e r!(*# (e (&$er$&e !# $*$"!)e#'r !+"&/e, *)*e)"e#e '" &: *)*e)"e-$'#*&&,
*)*e)"e-e%*#$&&, *)*e)"e-$*$e)$&& $!* *)*e)"e +* %!& %*#"e !8e %&"e $!* '#&!8&+e4 ;
Unguenta, FR .
FR , $*#. 200
7/24/2019 tehnologie farmaceutic
2/53
e$"e 25 - FR 4 &&, e$"e !)*%&"e
+')+e)"r!>&& '" & e#*r& ?&(r'e $!* #&'e 'r!)'e#*r& $!* '#e'e#*r&4. A* *)+" (e
7/24/2019 tehnologie farmaceutic
3/53
*)*e)"L@H +re%e,U)*e)"e-$*$e)$&& !$"e4,U)*e)"e-'#&!8&+e %&"e4
Pr'+e(e*# (e !r&+!>&e
U)*e)"e $"ere
U)*e)"e#e '"!#%&+e,U)*e)"e#e +* !)"&&'"&+e,U)*e)"e#e !(%&)&$"r!"e e r)&(e$+?&$e, &e#e! #e8!", &e#e!$*!r'r
U)*e)"e e)"r* +!re $e
re/e(e ' !)*%&"
S"r!"*# $*er&+&!# !# &e#&&
U)*e)"e e)('(er%&+e, +*!+>&*)e %!& &e
A*) (e #! #'+*# (e !(%&)&$"r!re
7/24/2019 tehnologie farmaceutic
4/53
CARACTERELE I CONTROLUL CALITII UNGUNETELOR
9) FR $*)" &&, ('8!re! $*$"!)>e#'r
%e(&+!%e)"'!$e.
Ex!"#$% &'&"'"%' !&'*&+&"
U)*e)"e#e "re*&e $ !& *) !$e+" '%'e) =& $ re8&)"e +*#'!re! =& %&r'$*#
+!r!+"er&$"&+e +'%')e)"e#'r.
Caractere vizuale
aspect: *)*e)"e#e "re*&e $ !& *) !$e+" '%'e) =& $ re8&)"e +*#'!re! =& %&r'$*#
+!r!+"er&$"&+ +'%')e)"e#'r !$e+"*# '!"e & (e$+r&$ +!:
$"r#*+&"'r, #*+&'$-%"$'$ $!"&)!"4 $!* %!"
"r!)$!re)", "r!)$#*+&(, '!#e$+e)" $!* '!+.
consistena: $e (e$+r&e r&):
' r&&(&"!"e, $"!re +'%!+" $!* !)"
' e#&&+!re er% $!* +!re "re%*r
omogenitate: *)*e)"*#
7/24/2019 tehnologie farmaceutic
5/53
+3-*# *)*e)"e#'r "re*&e $ &e +*r&)$ &'%e"r&+. 9) +!8*# ?&(r'e#*r'r, H-*# '!"e & (e"er%&)!" (&re+" e
r'(*$ $!* r&) (*!re +* !.
D""'!#'" **"#"
C')$&$"e)>! e$"e (e&)&" +! r'r&e"!"e! *)*e)"*#*& (e ! $e '*)e #! (e'r%rer'/'+!"e (e 'r>e#e e"er&'!re e! re#e/ +!r!+"ere#e re'#'&+e !#e *)*e)"*#*& +!: r&&(&"!"e!
(*r&"!"e!, #!$"&+&"!"e!, &'!(e8&/&"!"e!, er%e!&"!"e!.
9) *)+>&e (e +')$&$"e)>, *)*e)"e#e $e +#!$&&+
7/24/2019 tehnologie farmaceutic
6/53
F 1 - 1,5 !8e (e *)*e)" &)(&ere)"e e)"r* &e#e,
F 1,6 - 1,D !8e (e *)*e)" +* !+!)"'8 /&8&, (!r %'(er!",
F 2 - !8e (e *)*e)" +* !+!)"'8 r')*)>!", F !8e (e *)*e)" +* !+!)"'8 '!r"e r')*)>!", &r&"!)"e e)"r* &e#e.
M!'r&"!"e! e+&&e)>'r !* !+"'r& (e !+!)"'8 %e(&&, B) #! 2, %!& *>&)
+'re$*)8"'!re $*)": /!$e#&)!, !r!&)!, *#e&*# (e r&+&).
C#*"'7'" 9) re+&&e)"e &)e
7/24/2019 tehnologie farmaceutic
7/53
AJE E UNGUENT - PREPARARE
!8e#e (e *)*e)" $*)" !#+"*&"e (e '&+e& (&) !%e$"e+*r& (e e+&&e)&, %!& r!r (&) *)*#
$&)*r. &) *)+" (e /e(ere +!)"&"!"&/ !+e$"e! rere8&)" +e! %!& %!re !r"e (&)"r-*) *)*e)" $&
&%r&%! re!r!"*#*& +')$&$"e)"! ('r&"!. !+! $*)" '#'$&"e +! !"!re !* !+>&*)e r'"e+"'!re #!
!$'+&ere! +* $*$"!)e !+"&/e /'r !/e! r'# "er!e*"&+.
O&)ere! !8e#'r (e *)*e)" r&) r'+e(e*# (e "'&re e$"e )e+e$!r !"*)+& +B)( !+e$"e! !*
*)+"e (e "'&re (&er&"e, $!* e$"e *K*r!" (&8'#/!re! *)'r r&)+&&& !+"&/e.
Pr&)
7/24/2019 tehnologie farmaceutic
8/53
T'!"e !+e$"e !8e #! !#&+!re e &e#e #!$ ' *r%! r!$! +!re )* $e '!"e & e%*#$&/e '" &)+'r'r! !! +! !8! &)"er)! $& $e )*%e$+ !8e (e !$'r>&e.
E: U)*e)"*# $&%#* F.R. 4,
U)*e)"*# +* !#+''#& (e #!)! F.R. I4
O $+?e%!"&8!re ! !8e#'r (e *)*e)" r!$e $-!r *"e! re8e)"!
7/24/2019 tehnologie farmaceutic
9/53
!$'#*" #! &erere, e)8e) $& +#'r''r%, *$'r $'#*! &) !+e"!" (e e", !+e"')!, e"er $& e"er (e
e"r'#, r!+"&+ &)$'#*! &) !! e$"e %&$+&! &) $"!re "'&"! +* *#e&*r& /ee"!#e $& !r!&)!
#&+?&(!. Are *)+"*# (e &+*r!re 36-2C.
V!$e#&)! !#! e$"e *) !%e$"e+ $e%&$'#&( (e ?&(r'+!r*r& $!"*r!"e, '"&)*"e (&) e"r'#,
*r&&+!"e $& (e+'#'r!"e. E$"e %!$! !#!, +* !$e+" '%'e), !)"!, ')+"*'!$!, '!+! &) $"r!" r'$ $&
"r!$#*+&(! &) $"r!" $*"&re, !r! %&r'$ $& !r! *$". I) $"!re "'&"! e !&! (e !! "re*&e $! $e
re8&)"e +! *) #&+?&( "r!)$!re)", !r! $e(&%e)", !r! &%*r&"!"& %e+!)&+e, !r! %&r'$ $& +* ' $#!!
#*'re$+e)"! /er(e-!#!$"r*&e. E$"e *$'r $'#*! &) !+e"')!, e)8e), +#'r''r%, r!+"&+ &)$'#*! &)
!!, !#+''#, #&+er'#.E$"e %&$+&! +* *#e&*r& r!$e $& !r!&)! #&+?&(!. Are *)+"*# (e &+*r!re 3-
55C.
!+! $e !(!*! +'#e$"er'# $!* !#+''# +e"&+ $e %!re$"e +!!+&"!"e! (e &)+'r'r!re ! !e&
!+e$"e! $e /'r $+!(e (&) +!)"&"!"e! (e /!$e#&)! !#! (&) 'r%*#! $& )* (&) #!)'#&)! (e'!re+e
#!)'#&)! (e"er%&)! +')$&$"e)"! re!r!"*#*&.
8A9E DE UNGUENT EMULSIE A:U
A+e$"e !8e (e *)*e)" +')"&) e+&&e)& #&'& +! !8! e"er)! $& !! $!* ' $'#*"&e
7/24/2019 tehnologie farmaceutic
10/53
OSERVATII
e +!"e 'r& $e re$+r&e #!)'#&)! $e /! '#'$& #!)'#&)! ?&(r!"!"! +* +')(&"&! +! $*$"!)"e#e
!+"&/e !$'+&!"e $! &e $"!e &) %e(&* !'$. !+! *r%!r&% &)+'r'r!re! *)'r +!)"&"!"& %!r& (e !!
$!* $'#*"&e !'!$! $e /! '#'$& #!)'#&)! !)?&(r!. L!)'#&)! ?&(r!"!"! '!"e +')&)e !)"&'&(!)"&, (!r &)
!+e$" +!8, !+e$"&! "re*&e %e)"&')!"& e e"&+?e"! re+&&e)"*#*&.
Se +')$er/! &) re+&&e)"e &)e &)+?&$e, er&" (e #*%&)!, #! +e# %*#" 25C.
INTREUINTARI
N* $e '#'$e="e +! !"!re /! &)"r! &) +'%'8&"&! *)'r !8e (e *)*e)" !#!"*r& (e !#"&e+&&e)"& #&'&.
8A9E DE UNGUENTE EMULSIE U:A
U)*e)"e#e e%*#$&e U@A !* ('* !8e:
- ' !8 e"er) rere8e)"!" (e ! $!* (e ' $'#*&e !'!$,
- ' !8 &)"er) +!re e$"e !#+"*&" (&) e+&&e)& #&'&.
9) $&$"e% $*)" re8e)& +'%')e)& +* r'r&e"& e%*#$&/e (e "& U@A, )e+e$!r& e)"r*
$"!&8!re! $&$"e%*#*&.
E%*#!"'r&& '#'$&& $*)":
7/24/2019 tehnologie farmaceutic
11/53
UNGUENTUM EMULSIFICANS (FR X)
U)*e)" e%*#!"'r
A#+'?'#*% +e"#$"e!r#&+*% e%*#$&&+!)$ 30
P!r!&)*% #&*&(*% 35
V!$e#&)*% !#*% 35
PREPARARE
A%e$"e+*# (e $*$"!)e $e "'eK"e e !&! (e ! K& !'& $e "r&"*re!8 B) #! r+&re e)"r*
'%'e)&8!re.
OSERVAII
A#+''#*# +e"$"e!r&+ e%*#!"'r $!* +e!r! L!)e""e $e '&)e (&):
Ce"$"e!r$*#!" (e $'(&* 10
A#+''# +e"$"e!r&+ D0
A 5
A#+''#*# +e"$"e!r&+ $e
7/24/2019 tehnologie farmaceutic
12/53
C+&""%'"
A."67"
C'&"'"&%"
G'. ."
+"#"''";# +"%"
S/%"
T%"'#&$#
A&$#""'+"$&
Ex"!+%"
7/24/2019 tehnologie farmaceutic
13/53
(e'$e&" &)+'%!"&&">'r e)er!"e %!& !#e$ (e +!r!+"er*# &')'e) !# +'%')e)"e#'r.*+"&"!"e! ?&(r'e#*r'r $!* ! ! e#*r'r +* PEG $e '!"e &! !+e$"'r!. Ge#*re *>&)/B$+'!$e $e *"&8e!8 +! & e)"r* +!"e"ere, %)*=& (e e!%&)!re $!*+?&r*r&+!#e. Ge#*re '" & *"&8!"e, (e !$e%e)e!, +! !8e (e *)*e)"
7/24/2019 tehnologie farmaceutic
14/53
!e&. 9) !+e$" $+' $e *"&8e!8 +! *%e+"!)>&: #&+er&)!, r'e)#&+'#*#, $'r&"'#*#, +!re !*" #!re>&)ere! !e&.
Conservanii "re*&e $ &e +'%!"&& +* !e)>&& 'r%!"'r& (e e#. N&!&) =& )&!$'#, &e
$&)*r&, &e &ere+'%!)(!"e $*)" (e 0,1-0,2 e)"r* )&!&) =& 0,02-0,05 e)"r* )&!$'#. A#>& +')$er/!)>&*"&8!>& e)"r* e#*r& $*)": +#'r'+re8'#*#, !+&(*# e)8'&+, +#'r*r! (e e)8!#+')&*, !+e"!"*# (e+#'r?e&(&).
UNGUENTUM MACROGOLI (FR X)U#1$"#$% &$ +%"%"#1%&%
M!+r''# 00 50M!+r''# 000 50
PREPARAREA%e$"e+*# $e "'e$"e e !&! (e !! #! !r'. 60'C $& !'& $e "r&"*re!8! !)! #! r!+&e e)"r*
'%'e)&8!re.
ESCRIEREU)*e)" '%'e), (e +*#'!re !#!, +* !$e+" $&(e'$, !r'!e !r! %&r'$.OSERVATIIM!+r''#&&, +!r'! $!* '#&e"e)#&+'#&& $*)" '#&%er& (e +')(e)$!re !& '&(*#* (e e"e)
+* !!. S*)" '!r"e *$'r $'#*& &) !!, !+e"')!, !#+''# $& +#'r''r% r!+"&+ &)$'#*& &) e"er,!r!&)! #&+?&(! $& *#e&*r& r!$e. S"!re! (e !re!re (e&)(e (! %!$! %'#e+*#!r!: %!+r''#&& 200 $&00 $*)" #&+?&(e /!$+'!$e, !r'!e &)+'#'re, #&%e8& +* %&r'$ $#! +!r!+"er&$"&+, +* *$" &)"!& (*#+e,
7/24/2019 tehnologie farmaceutic
15/53
UNGUENTUM GL>CEROLI (FRX)U#1$"# &$ 1%&"'%
A%#*% 7,00Me"?#&$!r!?(r'e)8'!$ 0,1Pr'#&$!r!?(r'e)8'!$ 0,02G#+er'#*% D3,00A*! (&$"#!"! 7,00
S&)')&%: #&+er'#!" (e !%&('), *)*e)" (e #&+er&)!.
PREPARAREI)"r-' +!$*#! (e 'r"e#!) &) re!#! +!)"!r&"! $& &)+!#8&"! $e !(!*! !%&(')*#, )&!e$"r&& $&
!! &)+!#8&"! #! !r'. 700C. Se #!$! #! &%&!" !r'&%!"&/ 10 %&)., $e !(!*! #&+er&)! &)+!#8&"! e!&! (e !! #! !r'. D00C $& $e &)+!#8e$"e e $&"! !)! #! e#&&+!re. Se +'%#e"e!8! +* !! &)+!#8&"!#! %!$! re/!8*"!.
ESCRIEREU)*e)" '%'e), &)+'#'r, "r!)$#*+&( +* %&r'$ +!r!+"er&$"&, ?&r'$+'&+.
OSERVATIIA%&(')*# e$"e ' *#ere &)!, !#!, !r! %&r'$ $& !r! *$". E$"e r!+"&+ &)$'#* &) !#+''# $&!! #! ' "e%er!"*r! &)"re -150C. Are ('*! +'%')e)"e: !%!8! +* $"r*+"*r! &'r%!, $'#*! &)!! $& !%'e+"&)! +* $"r*+"*r! r!%&&+!"! +!re 'r%e!8 ' re>e! "r&(&%e)$&')!#! re$')$!! (e$"r*+"*r! (e e#.
E&$"! %!& %*#"e $'r"*r& (e !%&(') &) *)+>&e (e r'/e)&e)"!: (e r!* , (e 'r*%, (e 're8,(e +!r"'&. Pe)"r* '>&)ere! #&+er'#!"*#*& $e reer! '#'$&re! !%&(')*#*& (e rB* +!re !re '$"!&"!"e %!& %!re $& e#&&+! #! ' "e%er!"*r! %!& $+!8*"!. A%&(')*# (e 'r*% $& (e 're8
7/24/2019 tehnologie farmaceutic
16/53
!(!*!$'#*"&!N!OH 10Q (*!"! +* 10 !!, $e '%'e)&8e!8! $& $e +'%#e"e!8! +* !! #! %!$!re/!8*"!.
ESCRIERE
U)*e)" '%'e), &)+'#'r, "r!)$#*+&( +* %&r'$ $#! +!r!+"er&$"&+.OSERVATIIC!r''#&& $*)" '#&%er& (e ?&(r'&/&), $'#*& &) $'#*"&& (e ?&(r'&8& !#+!#&)& $& !r"&!#&
$'#*& &) !!. A* "e)(&)"! (e ! $e !#'%er! &) !! $& (e !+ee! $e re$!r! (e!$*r! !e& $* !&"!re.Se '" #!$! #! &%&!" !)! #! 2?. #! !(!*!re!N!OH !re #' (&8'#/!re! $& e#&&+!re! &) !+e#!$&"&%. Ge#* (e +!r''# e$"e $"! #! *) H +*r&)$ &)"re 5,5 ; 10 *) e+e$ (e N!OH (*+e #!$+!(ere! +')$&$"e)"e&, !+e!$"! )* e$"e &)#*e)"!"! (e "e%er!"*r!. Pe)"r* )e*"r!#&8!re $e '!"e '#'$&$& "r&e"!)'#!%&)!. E$"e *) e# !)&')!+"&/ $& )* $e '!"e !$'+&! +* $*$"!)"e+!"&')!+"&/e.C')+e)"r!"&! &) +!r''# '!"e /!r&! &)"re 0,5-5Q &) *)+>&e (e +')$&$"e)"! ('r&"!.
T!e# 2Ne*"r!#&8!re! +!r''#*#*& & $'#/e)>&
S%7"#
A1"# #"$'%6# (1:1 C'/+%)
NO30, - 0,4
TEA?,? - ?,
T'"%!#0,B - ?,0
A!
7/24/2019 tehnologie farmaceutic
17/53
INTREUINTARI!8! (e *)*e)" #! '"&)ere! *)*e)"e#'r %e(&+!%e)"'!$e.
CONSERVAREI) re+&&e)"e &)e &)+?&$e, #! +e# %*#" 250C.
PROPRITILE AJELOR E UNGUENT HIROSOLUILE
G"% ." !&'1%(FR X)
G%&"'% ."!.# (FR X)
G"% ." &'/+% ?
C!+6"
D$'"
C+&" "%'"
A."67"
C'&"'" &%"
G'. ."
7/24/2019 tehnologie farmaceutic
18/53
&)B)( $e!%! (e !+e$"e r'r&e"& !#e $*$"!)e#'r, (&$er$!re! #'r
7/24/2019 tehnologie farmaceutic
19/53
I'( 0. ; 1 6 - S'#*
I?"&'# M&$+& M&$+& M&$+& M&$+&
Me)"'# 1 ; 20 17 ; 1 15 ; 1 M&$+&
Re$'r+&)'# - - ; 6.7 S'#*
+'#'r!"&&4
S*#!%&(e - - 0.7 ; 0.D S'#*+'#'r!"&&4
UNGUENTUM CAMP3ORAE ?0 U)*e)" +!%'r!" 10
C!%?'r!e 10U)*e)"*% $&%#e D0
OSERVATIIC!%'r*# e$"e ' $*$"!)"! re* $'#*! &) !!, (!r *$'r $'#*! &) *#e&*r& $& r!$&%&.
&8'#/!re! +!%'r*#*& &) e+&&e)" $e !+e +* r&! e)"r* ! e/&"! &er(ere (e $*$"!)"! r&)0
7/24/2019 tehnologie farmaceutic
20/53
C')$&$"e)"!
C!r!+"ere "!+"e
C!!+&"!"e (ee"!#!re
Gr!( (e e)e"r!re&) &e#e
C')(&&')!re K&+')$er/!re
I)(&+!&&"er!e*"&+e
UNGUENT CU XILOCAINA 2
'+!&)! +#'r?&(r&+! 2H&(r'e# (e +!r''# D0 .$.!( 100
OSERVATII'+!&)! +#'r?&(r&+! e$"e ' $*$"!)"! *$'r $'#*! &) !! $& $'#*"&! '"&)*"! $e '!"e
7/24/2019 tehnologie farmaceutic
21/53
C')$&$"e)"!
C!r!+"ere "!+"e
C!!+&"!"e (ee"!#!re
Gr!( (e e)e"r!re&) &e#e
C')(&&')!re K&+')$er/!re
I)(&+!&&"er!e*"&+e
UNGUENTE SUSPENSII
!+! $*$"!)"! $'#&(! e$"e &)$'#*! &) e+&&e)", +!" $& &) !#"& $'#/e)"& e: (er%!"'#, $*#,&$%*" $*)&"r&+, '&( (e 8&)+, e"+.4 $e re+*re #! $*$e)(!re &) !8! (e *)*e)". I) !+e$" +!8$*$"!)"! $e !(*+e &) $"!re (e *#ere '!r"e &)! K& +?&!r e"r!&) $&"! VIII, re$e+"&/ I4.C')'r% FR D0Q !r"&+*#e $*$e)(!"e "re*&e $! re8&)"e *) (&!%e"r* (e +e# %*#" 50 %, &!re)"r* 10Q (&) !r"&+*#e $e !(%&"e *) (&!%"r* (e +e# %*#" 100 %.
!+! r'+e)"*# (e $*$"!)"! $*$e)(!"! e$"e $* 5Q, !+e$"! (*! *#/er&8!re re!#!!, $e
7/24/2019 tehnologie farmaceutic
22/53
e&)&&!re!r!"*#*&
S*$"!)"e !+"&/e $&r'r&e"!"&
!8! (e *)*e)"
S*$"!)"e !*&!re$& r'# &) 'r%*#!re
Gr!( (&$er$&e@%e"'(! re!r!re
Te?)&+! (e #*+r*
A$e+"
C')$&$"e)"!
C!r!+"ere "!+"e
C!!+&"!"e (ee"!#!re
7/24/2019 tehnologie farmaceutic
23/53
e&)&&!re!r!"*#*&
S*$"!)"e !+"&/e $&r'r&e"!"&
!8! (e *)*e)"
S*$"!)"e !*&!re$& r'# &) 'r%*#!re
Gr!( (&$er$&e@%e"'(! re!r!re
Te?)&+! (e #*+r*
A$e+"
C')$&$"e)"!
C!r!+"ere "!+"e
C!!+&"!"e (ee"!#!re
7/24/2019 tehnologie farmaceutic
24/53
re+& !& %'!r*#*& $& !% '"&)e *) re!r!" )e+'re$*)8!"'r +* r*)&. A+&(*# $!#&+&+ re!+"&')e!8!+* %e"!#e#e re#e $& )* /'% '#'$& #! re!r!re *$"e)$e %e"!#&+e $& )&+& $&"! +* &r %e"!#&+. C')'r%FR I, &) "&% !+e$" *)*e)" $e '" 'r%! r*)&, +!8 &) +!re )* $e %!& '#'$e$"e.
T/"% U#1$"# &$ x. ." 6#& H &. *%&%&e&)&&!re!r!"*#*&
S*$"!)"e !+"&/e $&r'r&e"!"&
!8! (e *)*e)"
S*$"!)"e !*&!re$& r'# &) 'r%*#!re
Gr!( (&$er$&e@%e"'(! re!r!re
7/24/2019 tehnologie farmaceutic
25/53
Te?)'#'&e F!r%!+e*"&+, A) IV, Se%. II, L.P. D, 20 - 2.0.2015
UNGUENTE MEDICAMENTOASE (II)
UNGUENTE EMULSII
!+ $*$"!)! !+"&/ )* e$"e $'#*
7/24/2019 tehnologie farmaceutic
26/53
G#+er'#& 10,00
U)*e)"& e%*#$&&+!)$ !( 50,00
A+&(*# 'r&+ $e (&8'#/ &! '>&)*" $e (&$er$e!8 &! (e !+&( 'r&+
7/24/2019 tehnologie farmaceutic
27/53
.$. e"er)
OSERVATII
!+ &*)e !)"&r*r&&)'!$! %e)"'#*#4, !)e$"e8&+ #'+!# r'+!&)!4, /!$'+')$"r&+"'!re ee(r&)!4,
!)"&&)#!%!"'!re $'#*"&! (e !+e"'"!r"r!" (e !#*%&)&*4.
R+. Re"&)'#& !+e"!"&$ 300 000 UI
U)*e)"& #&+er'#& 0
M.. *)*e)"*%
.$. e"er)
OSERVATII
U)*e)"*# +* #&+er'# !re $#!e r'r&e"!"& e%*#$&/e. I)+'r'r!re! $'#*"&e& *#e&'!$e $! !+e %!& %*#" (!"'r&"!
+')$&$"e)"e& r&(&+!"e ! *)*e)"*#*& $e '"&)e ' +/!$&e%*#$&e. Se reer! '#'$&re! $'#*"&e& +')+e)"r!"e (e /&"!%&)! A
*#e&'!$e e)"r* ! )* !e+"! '%'e)&"!"e! re!r!"*#*&. I) +!8*# &) +!re $e re$+r&e ' +!)"&"!"e %!& %!re (e $'#*"&e
7/24/2019 tehnologie farmaceutic
28/53
e$+r&ere
O$er/!&&
C')(&&')!re K&+')$er/!re
I)(&+!&& "er!e*"&+e
EXEMPLE DE UNGUENTE EMULSIE INDUSTRIALE5
F"#%/$6# &'"!
S*$"!)"e %e(&+!%e)"'!$e: e)*"!8')! , +!%'r 3, %e)"'# 1
E+&&e)"&: !#+''# +e"$"e!r&+ e%*#$&&!)" "& A L!)e""e N4, '#&$'r!" 0, #&+er'#, /!$e#&)! !#!, )&!e$"er&,
!! (&$"!"!.Ce!r! L!)e""e N e$"e ' !8! !*"'e%*#!"'!re (e "& U@A, +* +!r!+"er !)&')&+. Se !$'+&!8! +* e+&&e)"& r!$& ;
/!$e#&)! e)"r* +re$"ere! /!$+'8&"!"&& re!r!"*#*& $& +* e+&&e)"& ?&(r'$'#*& ; #&+er&)!. Pe)"r* ! !/'r&8!
e%*#$&')!re! +'%')e)"e#'r $& $"!&"!"e! re!r!"*#*& $e *"&8e!8! *) e%*#!"'r )e&')&+ (e "& U@A ; "ee) 0.
E+&&e)"*# '#'$&" e$"e ' !8! e%*#!"'!re (e "& U@A, #!/!!, *$'r (e e"!#!" $& +* e)e"r!&!"e *)! &) &e#e #!
!#&+!re! e "e*%e)"e r'(*+e ' *$'!r! $e)8!"&e (e r!+'r&re (!"'r&"! &er(er&& !r"&!#e ! /e?&+'#*#*& !'$.
7/24/2019 tehnologie farmaceutic
29/53
UNGUENTE POLIFA9ICE (MIXTE)
Ex"!+%" ." $#1$"#" !x" !1*'%"
R. A+&(& $!#&+&+& 2.50
Re$'r+&)'#& 2.00
S*#*r&$ r!e+&&"!"& 2.50
U)*e)"& $&%#&+&$ .$.!( 50.00
M.. *)*e)"*%
.$. e"er)
'bservatii
A+&(*# $!#&+&+ $e (&8'#/! !r"&!# &) !8! (e *)*e)" re8'r+&)! e$"e $'#*! &) !! &) r!'r" (e 1:1 $e (&8'#/!
&) 2 !! e)"r* ! '"&)e $'#*"&e !'!$! +!re $e /!
7/24/2019 tehnologie farmaceutic
30/53
'bservatii
H&(r'+'r"&$')*# !+e"!", "!#+*#, $*#*# re+&&"!" $& '&(*# (e 8&)+ $*)" &)$'#*e &) !8! (e *)*e)".
Re8'r+&)! e$"e $'#*! &) !! 1:1 $& $e /!
7/24/2019 tehnologie farmaceutic
31/53
T!e# 2. E/!#*!re! *)*e)"e#'r '#&!8&+e
e&)&&!re!r!"*#*&
F'r%*#!re S*$"!)e !+"&/e !8 (e *)*e)" S*$"!)e !*&!re @r'#
7/24/2019 tehnologie farmaceutic
32/53
TEHNOLOGIE FARMACEUTICA, F.IV, S. II, 22-26.0.2013, LP. 10
UNGUENTE MEDICAMENTOASECU EXTRACTE, GUDROANE
9)+'r'r!re! e"r!+"e#'r /ee"!#e
7/24/2019 tehnologie farmaceutic
33/53
C$."#I+?"&'# 1.50
E"r!+" (e H!%%!%e#&$ %'!#e 0.13O&( (e 8&)+ 15.00O&( (e "&"!) 6.00'r! 0.10
E+&&e)" !( 100.00
O&(*# (e 8&)+ $& (e "&"!) *#/er&8!"e &) $e "r&"*re!8 +* ' +!)"&"!"e (*#! (&) e+&&e)"*#"'&" *)*e)" $&%#*4 $e !(*! re$"*# (e e+&&e)" $& $e '%'e)&8e!8.
E"r!+"*# (e H!%%!%e#&$ $e "r&"*re!8 &)"r-*) !#" %'!r +* ' +!)"&"!"e e!#! (e !!, &!r'r!*# $e (&8'#/! &)"r-' +!)"&"!"e %&)&%! (e !!. A+e$"e $'#*&& $e e%*#$&')e!8 &) *)*e)".I?"&'#*# e$"e %&$+& +* !8e#e r!$e $& $e /!
7/24/2019 tehnologie farmaceutic
34/53
$ re8&)"e *) $e+"r* !)"&%&+r'&!) #!r K&
7/24/2019 tehnologie farmaceutic
35/53
e%*#$&')e!8! &) !8! (e *)*e)".L! re!r!re! *)*e)"e#'r '"!#%&+e $e '" !$'+&! $*$"!)"e !*&!re: !)"&'&(!)"&,
$"!&8!)"&, +')$er/!)"& !)"&%&+r'&e)& !(e+/!"& FR 4.
U)*e)"e#e '"!#%&+e $e +')(&"&')e!8! &) re+&&e)" $"ere, &)+?&$e e"!)$ +!re +')"&) +e# %*#"10 *)*e)" '"!#%&+, #! +e# %*#" 250C.
U#1$"#$! +
7/24/2019 tehnologie farmaceutic
36/53
)!"!%&+&) +!)(&('8e *)&$"!"&+ K&*)&+&(4
!)"&*)&+e#e !* $e+"r* #!r (e !+&*)e, )*r'(*+ $e)$&&8r& K& )* "e!8"e*%e)"e#e
+#'"r&%!8'# (er%!"'&&
e+')!8'# +!)(&('8e
%&+')!8'# +!)(&('8e
e"'+')!8'# &"&"&!8&$ /er8&+'#'r
"er&)!&) (er%!"'&& *)&+&(4
)!"&&) (er%!"'&& *)&+&(4
!8e#e (e *)*e)" "re*&e !#e$e +'re$*)8!"'r !$"e# &)+B" $ !$&*re ' *) +')$er/!re !!)"&&'"&+*#*& K& $ er%&" (&*8!re! #*& (&) e+&&e)" &) &e#e. A)"&&'"&+e#e &)$"!e &) %e(&* !'$$e
7/24/2019 tehnologie farmaceutic
37/53
C#'r!%e)&+'#*# $e re8&)"! +! ' *#ere !#! $!* !#-!#*&e, +* *$" '!r"e !%!r,)e?&r'$+'&+. Se (&8'#/ re*
7/24/2019 tehnologie farmaceutic
38/53
$ )* &r&"e K& $ )* $e)$&&8e8e &e#e!
$ )* &e %e(&* r&e#)&+ e)"r* (e8/'#"!re! %&+r''r!)&$%e#'r
$ $e
7/24/2019 tehnologie farmaceutic
39/53
S'#*"&' ?e)#?(r!rr& 'r!"&$ 0,02 1,00S'#*"&' !+&(& 'r&+& 3 5,00L!/!)(*#!e !e"?er'#e& 0,50
A*! (&$"#!"! .$.!( 100,00
Pre!r!"*# $e '&)e r&) !%e$"e+!re! ?&(r'e#*r'r +* "ee)-*# $& +'%')e)"e#e #&'e#*&(&&+!"e K& $e '%'e)&8e!8 B) #! r+&re. Se !(!* $'#*&e !'!$e (e !+&( 'r&+,'r!"e)%er+*r&+ K& *#e&*# (e #e/)&+. Se +')(&&')e!8
7/24/2019 tehnologie farmaceutic
40/53
3. UNGUENTE FOTOPROTECTOARE
U#1$"#" =+'"&'"
A+e$"e re!r!"e "re*&e $ re!#&8e8e ' r'"e+&e ! &e#&& ! (e !+&*)e! )'+&/ ! r!(&!&'rer&"r'e)e K& +!)+er&e)e K& $ )*
7/24/2019 tehnologie farmaceutic
41/53
9)r&&re! &e#&& !re +! $+' $ re/&) $!* $ &e: +re%e e%'#&e)"e $!* +'#(+re%e, +re%e e !8 (e $"e!r!>&, +re%e e !8
(e #!)'#&), +re%e +* /!$e#&), +re%e !+&(e, +re%e )*"r&"&/e.
* $+'*# *"&8r&&: +re%e )*"r&"&/e, +re%e ?&(r!"!)"e, +re%e +')"r! r&(*r'r, +re%e
!)"&$'#!re, +re%e (e 8&, +re%e (e )'!"e.
MATERII PRIME FOLOSITE LA PREPARAREA CREMELOR COSMETICE
S*$"!)e r!$e ; 'r&&)e !)&%!# ; +e!r, #!)'#&)!, +e"!+e*, !#+''#& (e #B),
Or&&)e /ee"!# ; *)" (e +!+!', *#e&*r& ; #'!re! $'!re#*&, %$#&)e, !r!?&(e, er%e)& (e
+ere!#e, *#e& (e r&+&),
Or&&)e %&)er!# ; *#e& (e !r!&), /!$e#&)!, !r!&)! $'#&(. A#"e $*$"!)e r!$e ; $"e!r&)!, !#+''# +e"&+.
E%*#!"'r& ; #!)'#&)!, $!), "ee), $r*r& !#e !+&8'r r!K& +* !%&)e 'r!)&+e
"r&e"!)'#!%&)e4.
S*$"!)e &'#'&+ !+"&/e ; /&"!%&)e, ?'r%')&, !%&)'!+&8&, #e+&"&)e, ?&(r'#&8!"e (e r'"e&)e,
7/24/2019 tehnologie farmaceutic
42/53
Nr. +r". A#"e +'%')e)"e Pr''r&e R'#
7/24/2019 tehnologie farmaceutic
43/53
G%&"'# #$ '"/$" * ."*+H"*& ?0 , ."'"&" "*"
7/24/2019 tehnologie farmaceutic
44/53
Fer%&"!"e! r'(*$*#*& - +!r!+"er&$"&+ +e e$"e (!" (e 'r! )e+e$!r e)"r* ! +'%r&%!r'(*$*#
7/24/2019 tehnologie farmaceutic
45/53
S$+6'"
S*'8&"'!re#e $*)" re!r!"e $'#&(e *)&('8e. F'r%!, /'#*%*# $& +')$&$"e)"! #'r $*)" !(!"!"e!(%&)&$"rr&& e +!#e re+"!#! P?. E*r. 6"?4.
E#e +')&) *)! $!* %!& %*#"e $*$"!)e !+"&/e (&$er$!"e &)"r-' !8! !(e+/!"!, +!re '!"e &$'#*! $!* (&$er$!! &) !! $!* $e '!"e "'& #! "e%er!"*r! +'r*#*&. !+! e$"e )e+e$!r $e '"!(*! e+&&e)& +!: (*!)&, !$'r!)&, $*r!+"!)"&, #*r&&!)&, +')$er/!)& !)"&%&+r'&e)& $&+'#'r!)& !*"'r&8!&.
O (e&)&&e !$e%)"'!re e$"e (!"! $& &) FR : Z$*'8&"'!re#e $*)" re!r!"e !r%!+e*"&+e$'#&(e +!re +')&) ('8e *)&"!re (&) *)! $!* %!& %*#"e $*$"!)e !+"&/e $*)" (e$"&)!"e !(%&)&$"rr&&e +!#e re+"!#!, /!&)!#! $!* *re"r!#! SUPPOSITORIA, FR 4, +!re r*e!8
7/24/2019 tehnologie farmaceutic
46/53
M.. $*'$&"'r&!.".(. )r. .S. e"er) 2 $*'8&"'!re e 8&
$!* $e re$+r&* $*$"!)e#e e)"r* )*%r*# "'"!# (e $*'8&"'!re $& #! instruc(io$e re/e(e divide indoses ae3uales$!* iant%+! &) ee%#*:R. Fe)'!r&"!# 1.00
A)"&&r&)! 2.00M.. $*'$&"'r&!&/&(e &) ('$e$ !e*!#e$ Nr. II.S. e"er) 2 $*'8&"'!re e 8&
e'!re+e #! )&/e#*# %*+'!$e#'r *)(e $e !#&+! !+e$"e re!r!"e %*+'!$! re+"!#!, /!&)!#!$!* *re"r!#!4 !re #'+ ' !$'"&e +'%!r!! +* +e! re!#&8!"! &) *r%! !(%&)&$"rr&& 'r!#e, $e &%*)e/er&&+!re! ('8e#'r re$+r&$e. I) +!#+*#*# (e /er&&+!re $e '#'$e$+ /!#'re ('8e#'r %!&%e e)"r* '(!"! $& e)"r* 2 (e 're '#'$&"e $& &) +!8*# re!r!"e#'r !(%&)&$"r!"e &)"er).
86" +"#'$ *$+6'"C! $& &) +!8*# *)*e)"e#'r, !8! e)"r* $*'8&"'!re +')$"&"*&e $*'r"*#, %!"r&! &) +!re $*)"
&)+#*$e $*$"!)e#e %e(&+!%e)"'!$e $& !#"e $*$"!)e !*&!re. E#e $*)" $*$"!)e $'#&(e, r!$e $!*?&(r'$'#*e, +!re !* +!!+&"!"e! (e ! 'r%! ' %!$! #!$"&+! %'(e#!! &) 'r%e !r%!+e*"&+e$'#&(e +')/e)!e !(%&)&$"rr&& e +!#e re+"!#!. Ce(!re! $*$"!)e#'r %e(&+!%e)"'!$e $e !+e &e(!"'r&"! !"*#*& +! e+&&e)"*# $e "'eK"e #! "e%er!"*r! +'r*#*&, &e e)"r* +! e+&&e)"*# e$"e?&(r'$'#* $& $e (&8'#/! &) $e+re&e %*+'!$e#'r.
E+&&e)&& "re*&e $! re8&)"e r'r&e"!"& !(e+/!"e e)"r*: re!r!re, $"'+!re $& *"&8!re!(%&)&$"r!re4.
1. L! re!r!re: $! !& *) &)"er/!# $*&+&e)" (e %!re &)"re *)+"*# (e "'&re $& *)+"*# (e
7/24/2019 tehnologie farmaceutic
47/53
Untu 'e %a%a!C!+!' '#e*% FR 4 e$"e r$&%e! '&)*"! (&) $e%&)e#e (e T?e'r'%!C!+!'. E$"e ' %!$! $'#&(!, #*&e, +* %&r'$ (e +!+!' $& *$" !r'%!". E$"e *K'r $'#* &) e)8e),e"er, *&) $'#* &) !#+''#, r!+"&+ &)$'#* &) !!.
&) *)+" (e /e(ere +?&%&+, e$"e *) !%e$"e+ (e "r&+er&(e !#e !+&8'r r!K& $!"*r!&$"e!r&+, '#e&+ $& !#%&"&+4$& )e$!"*r!"& !+&( '#e&+ 37-3D4 Are *) *)+" (e "'&re re#!"&/ +''rB":32-350C. eK& re8&)" ' &)'+*&"!"e *)!, !re $& &)+')/e)&e)"e: '#&%'r&$%, +!!+&"!"e re(*$! (e&)+'r'r!re ! !e&, +')"r!+&e (e /'#*% re(*$! #! $'#&(&&+!re, $e '!"e '&(! rB)+e8&4.
Pre8&)" 'r%e '#&%'re: [, \, ] $& ] +* *)+"e (e "'&re 1, 22, 2 $& 30C. 9)+#8&re! #!"e%er!"*r& (e e$"e 00C (*+e #! '&)ere! 'r%e#'r &)$"!e [, \, ] 4 +* *)+"e (e "'&re $+8*"e,+ee! +e +')$"&"*&e ' (&&+*#"!"e e)"r* '&)ere! $*'8&"'!re#'r r&) r'+e(e*# (e "'&re $& "*r)!re.Re/e)&re! #! 'r%! $"!! ], !re #'+ &) "&% 1- 8e, *)+&e (e "e%er!"*r! (e $"r!re.
I)+'r'r!re! $*$"!)e#'r !+"&/e &) *)"*# (e +!+!' $e !+e &) *)+&e (e r'r&e"e &8&+'-+?&%&+e !#e !+e$"'r!. U)e#e $*$"!)e %e(&+!%e)"'!$e $*)" $'#*e &) *)"*# (e +!+!': !)e$"e8&)!0.5-1Q, +!%'r -10Q, +#'r!#?&(r!" -10Q, %e)"'# 10-15Q, e)'# 3-Q. U)e#e (&)"re !+e$"e!+#'r!#?&(r!", e)'#, +!%'r4 (e"er%&)!, (ee)(e)" (e +!)"&"!"e! #*!"! &) #*+r*, $+(ere! *)+"*#*& (e"'&re. I) !+e$"e +!8*r& $e '" !$'+&! r'(*$e +* *)+" (e "'&re %!& r&(&+!" +e!r! !#!, +e"!+e*4.
G$%er$'ee e#$$ntet$%e$e '&) r&)"r-' $er&e (e r'+e(ee +!re '#'$e$+ +! %!"er&& r&%e*#e&*r& /ee"!#e !r!?&(!, +'+'$, !#%&er4. Se '#'$e$+ *r%"'!re#e %e"'(e: U#e&*# /ee"!# $e ?&(r'e)e!8 e)"r* ! re(*+e r!(*# (e )e$!"*r!re, +re$+B)( !$"e# r''r&!
(e "r&+er&(e $'#&(e "r&+er&(e#e +* *)+" (e "'&re $+8*" $e e#&%&)! r&) e"r!+&e +*
$'#/e)& $!* r&) re$!re
Pr'+e(e*# (e &)"er-e$"er&&+!re $!* "r!)$e$"er&&+!re, #e!+ (e #! *#e&*# (e !#%&er '!" &) !+&(
7/24/2019 tehnologie farmaceutic
48/53
(ee)(e)" (e r''r&! (e e#!"&)!, #&+er&)! $& !!, *"ere! (e e#&&+!re ! e#!"&)e&, re8e)"! *)'r$*$"!)e +!re re!+&')e!8 +* e#!"&)!.
P'"+''" *$+6'"%'E&$"! "re& %e"'(e e)"r* re!r!re! $*'8&"'!re#'r: r&) %'(e#!re, r&) "'&re $& "*r)!re $&r&) re$!re.
Me"'(! r&) %'(e#!re $e '!"e re!#&8! )*%!& +* e+&&e)& r!K& *)" (e +!+!' $!*
7/24/2019 tehnologie farmaceutic
49/53
100 % $& %!& %*#" (e 100 % _ 5Q
C#'%$% '"6*"#" !"&" (FR X S$+%!"# 2004)C')"r'#*# re8&$"e)"e& %e+!)&+e $e !+e e)"r* ! !re+&! re8&$"e)"! $*'8&"'!re#'r +* '+!8&!
"r!)$'r"*#*&, (e'8&"!r&& $!* (&/er$e#'r re$&*)& !++&(e)"!#e #! +!re e$"e $**$ $*'8&"'r*#. A+e!$"!re8&$"e)"! (e&)(e (e e+&&e)&& '#'$&&, $*$"!)e#e !+"&/e &)+'r'r!"e, r'+e$*# "e?)'#'&+ (ere!r!re. Re8&$"e)"! %e+!)&+! $e er&%! &) r!%e e)"r* (e"er%&)!re! !+e$"e& re8&$"e)"e $*)"*"&8!"e ' $er&e (e r'+e(ee, (&)"re +!re ' %e"'(! r!+"&+! $& $&%#! e$"e (!"! (e *+?& $& O$+?.
e"er%&)!re! re8&$"e)"e& #! (e'r%!re (* !+e$" r'+e(e* $e !+e !$"e#: $*'8&"'r*# +* '
!8! ere+" #!)!, !# +r*& /Br ! '$" "&!" #!), $e !$e!8! &) %'+*# *)*& +&)(r* (e $"&+#! $!*#e!$ +* ere& r'K&, !/B)( (&!%e"r*# (e 2 +%. Pe $*'8&"'r $e !$e!8! *) +&)(r* +!re $e!(!"e!8 ere+" $& +!re #! !r"e! $*er&'!r! !re ' #!+! e +!re $e !$e!8! re*"!"&. C&)(r*#&)"er&'r
7/24/2019 tehnologie farmaceutic
50/53
P'"+''" *$+6'"%' '"&%" &$ "x&+"# %+*%$/% +'# +'" * $'#'"
Pr&) %'(e#!re )* $e '&) $*'8&"'!re &(e)"&+e +! 'r%! $& re*"!"e, &!r e+&&e)"*# +e# %!&+')/e)! e$"e ('!r *)"*# (e +!+!'. Ce#e#!#"e !8e (e $*'8&"'!re &&)( #&$&"e (e #!$"&+&"!"e, $ere#*+re!8 re* r&) %'(e#!re. Pe)"r* (eK&re! !+e$"'r &)+')/e)&e)"e $e re+*re #! '&)ere!$*'8&"'!re#'r r&) "'&re $& "*r)!re.
CB)( $e *"&8e!8 !+e!$"! %e"'(! "re*&e $! $e "&)! +')" (e +'%'r"!%e)"*# *)"*#*& (e+!+!' #!
7/24/2019 tehnologie farmaceutic
51/53
S$+6'" &$ &. &"%*%&%& %'(e#!re %!)*!#4A+&( !+e"$!#&+&+ 0,0
C!+!' '#e*% 1,60 M.. $*'$&"'r&!.".(. )r. .S. e"er) 2 $*'8&"'!re e 8&
T!e# 1. S*'8&"'!re +* !+&( !+e"$!#&+&+e&)&&! re!r!"*#*&
M". ."+'"+''"S*$"!)! !+"&/ K& r'r&e"&
Ex&+"# H
+'+'"
S$++&'" AM C& %"$!
O$er/!&&
Gr!( (&$er$&e
A$e+"
7/24/2019 tehnologie farmaceutic
52/53
T!e# 2. E/!#*!re! r'r&e"'r e+&&e)'r #&'$'#*&U# ." && (FR X) S$++&'" AM
Or&&)e K& %e"'(! (e'&)ereA$e+"
S'#*&"!"e
C'%'8&&e +?&%&+
H&(r'&e&)(&+e (e ?&(r'P*)+" "'&re
Pr'r&e"& "e?)&+e
S"!&"!"e&)(&+e (e &'(,&)(&+e er'&(4I)'+*&"!"e
&$er$!re!$*$"!)e#'r !+"&/eCe(!re! $*$"!)e#'r
%e(&+!%e)"'!$eMe"'( (e re#*+r!re
C')$er/!re
52
7/24/2019 tehnologie farmaceutic
53/53
Ex"!+%" #.$*'%" ." *$+6'"
3"!'6# A)"&&'"&+e I!$&4C'%'8&"&e e)"r* *) $*'8&"'r: ?&(r'+'r"&8') .D , "e"r!+&+#&)! 20 %, e)8'+!&)! .3 , +#'r?&(r!" (e r'+!&)! 5 %E+&&e)"&: *)" (e +!+!' (er&/!" e%+!' ; *)" +!+!' NCHO 3554, !r!&)! #&+?&(!.
I#.!"$*'8&"'!reC'%'8&"&e e)"r* *) $*'8&"'r: &)('%e"!+&) 50 %E+&&e)"&: #&+er&(e (e $e%&$&)"e8!, %!+r''##&+er'# ?&(r'&$"e!r!".
C%="#$*'8&"'!reC'%'8&"&e e)"r* *) $*'8&"'r: (&+#'e)!+ $'(&+ 100%E+&&e)"&: *)" (e +!+!' (er&/!", *#e& (e !r!&)!.
U%'+'&, $*'8&"'!reC'%'8&"&e e)"r* *) $*'8&"'r: #*'+'r"'#') &/!#!" +'r"&+'$"er'&(4, #*'+'r"'#') +!r'!", +&)+'+!&) ?&(r'+#'r&( !)e$"e8&+ #'+!#4
E+&&e)"&:r$&%& $'#&(e (e $e%&$&)"e8 ^&"e$'# 354.
J"#%, $*'8&"'!reC'%'8&"&e e)"r* *) $*'8&"'r: e"'r'e) 100 %E+&&e)"&: r!$&%& $'#&(e, "r&+er&(e +* #!)" %e(&*.
%'"#, $*'8&"'!reC'%'8&"&e e)"r* *) $*'8&"'r: (&+#'e)!+ $'(&+ 50 % $!* 100 %E+&&e)"&: r!$&%& $'#&(e (e $e%&$&)"e8! !8! (e $*'8&"'r 54
S%=%K-00, $*'8&"'rC'%'8&"&e e)"r* *) $*'8&"'r: %e$!#!8&)! !+&( 5-!%&)'$!#&+&+4E+&&e)"&: !8! r!$!, (&'+"-$*#'$*++&)!" (e $'(&*, !#+''# +e"&+.